Republished with permission from DiabetesMine.com.
I had the most absurdly frustrating phone briefing yesterday with a company developing a very promising new technology for delivering insulin in an oral gel cap: Oramed Pharmaceuticals based in Jerusalem, Israel.
Oddly, I was contacted by their PR/Investor Relations firm with the express purpose of "getting the word out to the public," but trying to pry any of the key details out of their execs felt a bit like talking to the Israeli Secret...
